Daily Journal Staff Writer
Pasadena-based Arrowhead Research Corp. announced the appointment of its first general counsel on Thursday. Patrick O'Brien started his new job at the biopharmaceutical company on Tuesday.
O'Brien said he was looking for a "small company" with a "great future," and was attracted to the technology at Arrowhead, which develops drugs used to treat chronic hepatitis and obesity...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In